These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34512026)

  • 21. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
    Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
    Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
    Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
    J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence, correlates, and predictive value of high-risk human papillomavirus mRNA detection in a community-based cervical cancer screening program in western Uganda.
    Nakalembe M; Makanga P; Mubiru F; Swanson M; Martin J; Huchko M
    Infect Agent Cancer; 2019; 14():14. PubMed ID: 31114629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme.
    Pulkkinen J; Kares S; Huhtala H; Kholová I
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Pap Smear: Validation of HPV Genotype and Host Methylation Profiles of
    Shen-Gunther J; Xia Q; Stacey W; Asusta HB
    Front Microbiol; 2020; 11():595902. PubMed ID: 33178175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
    Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
    Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immediate risk of HSIL presence in women who have both ASC-US cytology and negative high-risk HPV test.
    Ozturk M; Umudum H; Aydin A; Ulubay M; Keskin U; Dede M; Yenen MC
    Eur J Gynaecol Oncol; 2016; 37(2):232-7. PubMed ID: 27172751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-16/non-18 high-risk human papillomavirus types predominate in anal cytology categories of negative for intraepithelial lesion and atypical cells of undetermined significance.
    Chebib I; Tetreault D; Tambouret RH
    J Am Soc Cytopathol; 2015; 4(6):344-351. PubMed ID: 31051749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.
    Munkhdelger J; Choi Y; Lee D; Kim S; Kim G; Park S; Choi E; Jin H; Jeon BY; Lee H; Park KH
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):422-7. PubMed ID: 24856365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papilloma virus genotype distribution in women with premalignant or malignant lesions of the uterine cervix.
    Stuebs FA; Gass P; Dietl AK; Schulmeyer CE; Adler W; Geppert C; Hartmann A; Knöll A; Beckmann MW; Koch MC
    Arch Gynecol Obstet; 2021 Sep; 304(3):751-758. PubMed ID: 33538863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping.
    Padhy RR; Davidov A; Madrigal L; Alcide G; Spahiu A
    Heliyon; 2020 Apr; 6(4):e03745. PubMed ID: 32346629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of human papillomavirus among Croatian women attending regular gynecological visit.
    Grahovac M; Racić I; Hadzisejdić I; Dorić A; Grahovac B
    Coll Antropol; 2007 Apr; 31 Suppl 2():73-7. PubMed ID: 17598508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests.
    Ge Y; Mody RR; Olsen RJ; Zhou H; Luna E; Armylagos D; Puntachart N; Hendrickson H; Schwartz MR; Mody DR
    J Am Soc Cytopathol; 2019; 8(3):149-156. PubMed ID: 31097291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance.
    Ding Z; Li Y; Chen A; Song M; Zhang Y
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():32-36. PubMed ID: 27816739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China.
    Liao L; Cheng H; Zeng F; Zhou W; Ding Y
    J Clin Lab Anal; 2019 Mar; 33(3):e22708. PubMed ID: 30390349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3.
    Del Pino M; Angeles MA; Martí C; Henere C; Munmany M; Marimon L; Saco A; Rakislova N; Ordi J; Torné A
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of HPV E6/E7 mRNA quantitative analysis in distinguishing high-grade cervical squamous intraepithelial lesions from low-grade cervical squamous intraepithelial lesions.
    Liu J; Yang T; Hu Y; Ye C
    J Virol Methods; 2021 Mar; 289():114014. PubMed ID: 33188806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
    Trzeszcz M; Mazurec M; Jach R; Mazurec K; Jach Z; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Prokopyk A; Barcikowski P; Przybylski M; Wach J; Halon A
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
    Knoepp SM; Kuebler DL; Wilbur DC
    Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.